1. Synthesis, molecular modeling, and pharmacological evaluation of new 2-substituted benzoxazole derivatives as potent anti-inflammatory agents
- Author
-
Radhakrishnan Subashini and Gangadhara Angajala
- Subjects
chemistry.chemical_classification ,Molecular model ,010405 organic chemistry ,Stereochemistry ,Benzoxazole ,010402 general chemistry ,Condensed Matter Physics ,Trypsin ,01 natural sciences ,In vitro ,0104 chemical sciences ,chemistry.chemical_compound ,Enzyme ,chemistry ,Docking (molecular) ,medicine ,Physical and Theoretical Chemistry ,Etodolac ,Prostaglandin H2 ,medicine.drug - Abstract
In the present work, 2-substituted benzoxazole derivatives were synthesized from 2-(benzo[d]oxazol-2-yl) aniline. All the synthesized compounds were purified and characterized by 1H NMR, 13C NMR, and mass spectroscopy. All the compounds were pharmacologically evaluated for its in vitro anti-inflammatory efficacy using membrane stabilization and proteinase inhibitory methods. In addition to this, in silico molecular docking studies were carried out to predict the binding affinity of the synthesized benzoxazole derivatives with prostaglandin H2 synthase (PGHS) protein and trypsin enzyme. The results obtained from in vitro anti-inflammatory studies showed that compound 3, 4, and 6a showed good efficacy with percentage inhibition of 74.26 ± 1.04, 80.16 ± 0.24, and 70.24 ± 0.68 for membrane stabilization activity 80.19 ± 0.05, 85.30 ± 1.04, and 75.68 ± 1.28 towards proteinase inhibitory efficacy at a concentration of 100 μg/mL which was on par to that of standards aceclofenac and etodolac. Molecular docking analysis showed that compounds 3 and 4 possess good binding affinity towards PGHS protein with a docking score of − 9.4 and − 9.3 kcal/mol respectively.
- Published
- 2019